诺力昂宣布其2019年全年财务业绩的盈利能力进一步增长，尽管在几个终端市场面临挑战。在利润管理和成本举措的推动下，调整后的EBITDA（息税折旧摊销前利润）增加了5%。销售额略有上升，因为销量的小幅下降被价格和产品组合效益所抵消。
这组财报结果是稳健可靠的。我们的卓越商业表现、运营改进计划以及成本控制举措表明，即使在市场环境充满挑战的情况下，我们也可以提高盈利能力。
—— Charlie Shaver
诺力昂首席执行官
调整后的EBITDA业绩的改善和强劲的现金流有助于公司在去杠杆方面的努力，包括在第四季度提前偿还了1.1亿美元（约合1亿欧元）的债务。近期，公司还成功完成了对欧元和美元定期贷款的重新定价，这使得年度利息支出减少了约1850万欧元。
Shaver先生补充说，诺力昂将继续在产能扩充和战略性收购方面进行投资，以支持其客户的增长。2019年公司在关键市场份额增长方面的投资包括在中国、墨西哥和美国的有机过氧化物扩产，以及在瑞典的硅溶胶和可膨胀微球的扩产。
诺力昂于2019年完成了对中国领先的烷基金属生产商的收购。公司近期还宣布了两项进一步优化产品组合的举措：收购邱博集团（J.M. Huber）的羧甲基纤维素（CMC）业务，以及将其可再分散乳胶粉业务出售给塞拉尼斯。
（以下为英文原版新闻发布）
Nouryon reports further growth in profitability in 2019
Nouryon reported further growth in profitability in itsfull-year 2019 financial results, despite challenging conditions in several endmarkets.Adjusted EBITDA increased by 5%, driven bymargin management and cost initiatives. Revenues were slightly up, as a smalldecline in volumes was more than offset by price and product portfolio mixbenefits.
“This is another solid set of results,” said Nouryon Chairmanand CEO Charlie Shaver. “Our commercial excellence and operational improvementinitiatives along with our cost discipline have shown that we can deliverimprovements in profitability even when market conditions are challenging.”The company’s improved adjusted EBITDA performance andstrong cash position have helped its deleveraging efforts, including an earlyvoluntary debt repayment of USD110 million (equivalent to approximately EUR100 million)in the fourth quarter. It also recently completed a successful repricing of itsEuro and US Dollar term loans, reducing annual interest payments byapproximately EUR18.5 million.Shaver added that the company continues to invest incapacity expansions and bolt-on acquisitions to support the growth of itscustomers. Key growth investments in 2019 included organic peroxide expansionsin China, Mexico and the US, and expansions of colloidal silica and expandablemicrospheres in Sweden.Nouryon also completed the acquisition of a leadingproducer of metal alkyls in China in 2019. The company recently announced twofurther proposed moves to optimize its portfolio; the acquisition of thecarboxymethyl cellulose business of J.M. Huber Corporation, and the divestmentof its redispersible polymer powders business to Celanese.
1) EBITDA adjusted to (i) eliminate certainnon-operating income or expense items, (ii) eliminate the impact ofcertain non-cash and other items that are included in profit for the period andEBITDA that the company does not consider indicative of its ongoing operatingperformance, (iii) eliminatecertain unusual items impacting results in a particular period and (iv) forperiods prior to January 1, 2019, reflect the pro forma effect of the impactfrom the future adoption of IFRS 16.
